RESULTS: SII, NLR, and PLR did not define patient groups with distinct clinicopathological characteristics. SII, NLR, and PLR cut-off values were 547, 2.13, and 88.23, as determined by ROC analysis; the corresponding areas under the curve (AUCs) were 0.625, 0.555, and 0.571, respectively. Cox regression models identified SII as independently associated with OS. Patients with low SII had prolonged OS (65 vs. 41 months, P = 0.017, HR: 3.24, 95% CI: 1.23-8.55). In the Z test, the difference in AUC between SII and NLR was statistically significant (Z = 2.721, 95% CI: 0.0194-0.119, P = 0.0065). CONCLUSION: Our study suggests that the pretreatment SII value is significantly correlated with OS in breast cancer patients undergoing NAC and that the prognostic utility of SII is superior to that of NLR and PLR.
RESULTS: SII, NLR, and PLR did not define patient groups with distinct clinicopathological characteristics. SII, NLR, and PLR cut-off values were 547, 2.13, and 88.23, as determined by ROC analysis; the corresponding areas under the curve (AUCs) were 0.625, 0.555, and 0.571, respectively. Cox regression models identified SII as independently associated with OS. Patients with low SII had prolonged OS (65 vs. 41 months, P = 0.017, HR: 3.24, 95% CI: 1.23-8.55). In the Z test, the difference in AUC between SII and NLR was statistically significant (Z = 2.721, 95% CI: 0.0194-0.119, P = 0.0065). CONCLUSION: Our study suggests that the pretreatment SII value is significantly correlated with OS in breast cancer patients undergoing NAC and that the prognostic utility of SII is superior to that of NLR and PLR.
Authors: Marcin Sinacki; Andrzej Badzio; Marzena Wełnicka-Jaśkiewicz; Jan Bogaerts; Martine J Piccart; Patrick Therasse; Ian E Smith; Thomas Hatschek; Jacek Jassem Journal: Breast Date: 2010-09-25 Impact factor: 4.380
Authors: Kar Wai Tan; Shu Zhen Chong; Fiona H S Wong; Maximilien Evrard; Sandra Min-Li Tan; Jo Keeble; D M Kemeny; Lai Guan Ng; Jean-Pierre Abastado; Véronique Angeli Journal: Blood Date: 2013-10-10 Impact factor: 22.113
Authors: Lars Johan Sandberg; Mark W Clemens; W F Symmans; Vicente Valero; Abigail S Caudle; Benjamin Smith; Henry M Kuerer; Limin Hsu; Steven J Kronowitz Journal: Plast Reconstr Surg Date: 2017-03 Impact factor: 4.730
Authors: Dilan A Patel; Jing Xi; Jingqin Luo; Bilal Hassan; Shana Thomas; Cynthia X Ma; Jian L Campian Journal: Breast Cancer Res Treat Date: 2019-01-02 Impact factor: 4.872
Authors: Ling Bo Xue; Yong Hong Liu; Bo Zhang; Yan Fang Yang; Dong Yang; Li Wei Zhang; Jian Jin; Jie Li Journal: Medicine (Baltimore) Date: 2019-01 Impact factor: 1.889